HOME >> BIOLOGY >> NEWS
Imaging technique may help in confirming, monitoring treatment of malignant brain tumors

In what is believed to be a first-of-its-kind study, Johns Hopkins researchers have used magnetic resonance imaging (MRI) to measure sodium concentrations in the cells of malignant brain tumors. Because growth of such cancers are linked to elevated sodium levels, an easy way to measure them could improve diagnosis and treatment monitoring. The study is published in the May 1 edition of Radiology.

"Determining precise sodium concentrations has been a problem, but MRI can do it at the same time it identifies possible malignant lesions," says Ronald Ouwerkerk, Ph.D., instructor of radiology at the Johns Hopkins Department of Radiology, MRI Research Division. Using proton MRI after injecting contrast agents to enhance areas containing many small blood vessels, the researchers found 50 percent more sodium in lesions that turned out to be malignant tumors than in normal brain tissue.

"Using MRI noninvasively in a single examination to get information about tumor metabolism and physiology improves identification of tumor malignancy and is a big step forward," says Ouwerkerk.

In the Hopkins study, 20 patients with brain malignancies confirmed by biopsy and nine subjects with no brain tumors underwent sodium MRI. Sodium concentrations were determined in malignant tumors, gray brain matter, white brain matter, cerebrospinal fluid and vitreou s humor (fluid within the eye). The image intensities in the sodium images were compared with the signals from a sample with known sodium content. The special scan method the researchers use for three-dimensional sodium MRI makes it possible to directly calculate sodium concentrations.

The researchers found sodium concentrations in cancer cells were elevated by an average of 50 percent compared to the other noncancerous tissues or those tissues in subjects with no tumors.

Elevated sodium, as an indicator of cancer, may be due to several factors. Among them are angiogenesis, development o
'"/>

Contact: Gary Stephenson
gstephenson@jhmi.edu
410-955-5384
Johns Hopkins Medical Institutions
1-May-2003


Page: 1 2

Related biology news :

1. Imaging the healing heart
2. Imaging study shows brain maturing
3. Imaging the brain solving problems through insight
4. Imaging technique reveals new structure in retinal cells
5. Imaging technique discovered at Stanford monitors cancer cell proliferation
6. Imaging study provides new information on how the brain processes sounds of different tones
7. Imaging apparatus characterizes drops in dirty laboratory environments
8. New Imaging Technique Pinpoints Dead Heart Muscle
9. Imaging Studies Illuminate Brains Response To Cocaine
10. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
11. New technique helps scientists reveal interactions between genes and drugs

Post Your Comments:
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
(Date:10/15/2014)... linked increased resistance to bacterial pneumonia in female mice ... estrogen. , Females are naturally more resistant to respiratory ... has shown that increased resistance to bacterial pneumonia in ... synthase 3 (NOS3). They also show that this enzyme ... sex hormone estrogen. , The team, lead by Professor ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to ... the development of skin cancers by turning on an ... skin cells. , Previously considered protective, SIRT6 is part ... help regulate genomic stability and prevent some of the ... damage, which can lead to cancer. This study, in ...
Breaking Biology News(10 mins):Sandata Announces Case Study with Quality Care Services, Inc. 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/25/2014)... October 24, 2014 Today, Nerium International, ... the winners of its “Reflect Your Youth” contest, an ... only seen a difference in their skin since using ... new outlook on life as a result of their ... as an effort by Nerium International to inspire conversations ...
(Date:10/25/2014)... , October 24, 2014 ... clinical-stage pharmaceutical company focused on the development of oral ... Nadav Kidron will present at FireRock Capital,s ... Capital,s Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ... New York City , ...
(Date:10/25/2014)... 2014 Research and Markets has ... Product , Research Area & by End User - ... In this report, the global epigenetics ... areas, and end users. The product segments of the ... & consumables, kits, and reagents. The subsegments of the ...
(Date:10/22/2014)... DUBLIN and BOSTON , ... ACT ), a leading global specialty pharmaceutical company, and ... been granted an exclusive option to acquire Rhythm,s wholly ... (RM-131), a peptide ghrelin agonist, for the treatment of ... Rhythm has completed a successful Phase 2 trial ...
Breaking Biology Technology:Nerium International™ Inspires Conversation About the Journey of Aging with “Reflect Your Youth” Contest 2Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 2Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5
Cached News: